Executive Director, Asset Project Leadership

North Tyneside, NE29 8EP, United Kingdom
3 weeks ago
Seniority
Director
Posted
15 Apr 2026 (3 weeks ago)

Your work will change lives. Including your own.

The Impact You’ll Make

At Recursion, our mission is to industrialize and transform the development of medicines by integrating data-driven insights and advanced analytics throughout the entire development lifecycle. As Executive Director, Asset Project Leadership, you will play a pivotal role ensuring advanced computational approaches and proprietary Recursion advantages are leveraged across the portfolio continuum, redefining traditional paradigms of drug development. As an asset project leader, you will work closely with functional lines to help craft, optimize and execute asset strategy, leveraging Recursion OS and Clin.Tech. insights to enhance program rigor and ultimately patient benefit. You will partner with preclinical, clinical and platform teams, promoting communication, alignment and optimization of functional processes to ensure delivery of portfolio goals & transformative medicines for patients.

In this role, you will:

  • Collaborate with functional leads across the portfolio to ensure seamless alignment, communication and execution of data-driven strategy from preclinical discovery through clinical development
  • Drive and enable a culture of accountability, ownership and innovation aimed at delivering prioritized medicines to patient populations in need.
  • Partner with key stakeholders including finance and functional line leadership to ensure project resourcing is strategically prioritized and deployed for the most impactful programs & work streams.
  • Establish and refine processes that maximally leverage Recursion OS and ClinTech insights for advancement of the internal/external drug discovery and development portfolios
  • Propagate the Recursion mindset of radically changing lives by constantly seeking transformative improvements in how we advance innovative concepts for clinical benefit.

The Team You’ll Join

As Executive Director, Asset Project Leadership, you will work within the Development team, reporting directly to the Global Head, Project Leadership. The Development Team is an empowered, execution-minded group of clinical development professionals responsible for translating and industrializing Recursion’s innovative science to patients. Our team leverages cutting-edge clinical technology to accelerate drug development, optimize trial design, and enhance patient outcomes. From deploying AI-powered platforms for data analysis and predictive modeling to integrating real-world evidence and biomarker discovery tools, we ensure our clinical programs are both efficient and precise.

The Experience You’ll Need

  • A PhD in life sciences or related scientific discipline with deep expertise in drug discovery & development
  • 10+ years of biotech/pharmaceutical industry experience with a proven track record of scientific asset project leadership, progressing drug discovery/development programs through stage-gates using data-driven decision making.
  • Expertise in cross-functional drug development and in-depth experience leveraging computational approaches to optimize assets.
  • Deep technical expertise in oncology, strength in additional therapeutic areas such as rare disease and immunology/inflammation a bonus.
  • Strong resource management and financial acumen

Working Location & Compensation:

This is an office-based, hybrid role in ourSalt Lake City or New York Cityoffices.Employees are expected to work in the office at least 50% of the time.

At Recursion, we believe that every employee should be compensated fairly. Based on the skill and level of experience required for this role, the estimated current annual base range for this role is$297,000 to $356,400. You will also be eligible for an annual bonus and equity compensation, as well as a comprehensive benefits package.

#LI-EP1

The Values We Hope You Share:

  • We act boldly with integrity.We are unconstrained in our thinking, take calculated risks, and push boundaries, but never at the expense of ethics, science, or trust.
  • We care deeply and engage directly.Caring means holding a deep sense of responsibility and respect - showing up, speaking honestly, and taking action.
  • We learn actively and adapt rapidly.Progress comes from doing. We experiment, test, and refine, embracing iteration over perfection.
  • We move with urgency because patients are waiting.Speed isn’t about rushing but about moving the needle every day.
  • We take ownership and accountability. Through ownership and accountability, we enable trust and autonomy—leaders take accountability for decisive action, and teams own outcomes together.
  • We are One Recursion.True cross-functional collaboration is about trust, clarity, humility, and impact. Through sharing, we can be greater than the sum of our individual capabilities.

Our values underpin the employee experience at Recursion. They are the character and personality of the company demonstrated through how we communicate, support one another, spend our time, make decisions, and celebrate collectively.

More About Recursion

Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.

Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn.

Recursion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation.

Accommodations are available on request for candidates taking part in all aspects of the selection process.


Recruitment & Staffing Agencies: Recursion Pharmaceuticals and its affiliate companies do not accept resumes from any source other than candidates. The submission of resumes by recruitment or staffing agencies to Recursion or its employees is strictly prohibited unless contacted directly by Recursion’s internal Talent Acquisition team. Any resume submitted by an agency in the absence of a signed agreement will automatically become the property of Recursion, and Recursion will not owe any referral or other fees. Our team will communicate directly with candidates who are not represented by an agent or intermediary unless otherwise agreed to prior to interviewing for the job.

Related Jobs

View all jobs
Spotlight

Senior Director Global Clinical Program Lead Cardiovascular & Renal

CSL
On-site

Senior Medical Director, Oncology Clinical Development - GU

GSK Stevenage, United Kingdom
Hybrid

Senior Medical Director, Oncology Clinical Development - GU

GSK United Kingdom
Hybrid

Senior Medical Director, Oncology Clinical Development - GU

GSK
Hybrid

Senior Medical Director, Oncology Clinical Development - GU

GSK
Hybrid

Senior Medical Director, Oncology Clinical Development - GU

GSK
On-site

Senior Medical Director, Oncology Clinical Development - GU

GSK
Hybrid

Industry Insights

Discover insightful articles, industry insights, expert tips, and curated resources.

Where to Advertise Biotech Jobs in the UK (2026 Guide)

Advertising biotech jobs in the UK requires a different approach to most technical hiring. The candidate pool spans life scientists, computational biologists, regulatory specialists and biomanufacturing engineers — each with distinct professional networks and job search behaviours. General job boards reach a broad audience but lack the specificity that biotech professionals expect. Specialist platforms, academic channels and sector-specific communities each serve a different part of the market. This guide, published by BiotechnologyJobs.co.uk, covers where to advertise biotech roles in the UK in 2026, how the main platforms compare, what employers should expect to pay, and what the data says about hiring across different role types.

Biotech Jobs UK 2026: What to Expect Over the Next 3 Years

Biotechnology is creating jobs at a rate that few other sectors can match. New disciplines are emerging from research labs and entering commercial hiring pipelines, existing roles are fragmenting into deeper specialisms, and the technologies driving it all — from AI-assisted drug discovery to next-generation gene editing — are advancing faster than the workforce can keep pace with. For job seekers, this creates an unusual challenge. In most industries, career planning means navigating a relatively familiar landscape and identifying where your skills fit. In biotech, that landscape is being actively redrawn. The roles generating the most hiring activity in 2028 may look quite different from the ones appearing in job adverts today. That's not a reason to feel overwhelmed — it's a reason to get informed. The candidates who thrive in this market aren't always those with the longest CVs or the most letters after their name. They're the ones who understand where the sector is heading: which disciplines are gaining commercial traction, which technologies are driving employer demand, and how the definition of a "biotech job" is expanding well beyond traditional pharmaceuticals and research roles. This article breaks down what the UK biotech jobs market is likely to look like over the next three years — covering emerging job titles, the technologies reshaping hiring, the skills employers are prioritising right now, and how to position your career ahead of the curve rather than behind it.

New Biotech Employers to Watch in 2026: UK and Global Companies Transforming Life Sciences Careers

The biotechnology job market in the UK is entering a new phase—one defined by scientific breakthroughs, targeted investment, and a growing pipeline of innovative employers. For professionals browsing BiotechnologyJobs.co.uk, the key question is no longer just which companies exist, but which ones are scaling, hiring, and shaping the future of life sciences. In this article, we explore the new biotech employers to watch in 2026, focusing on UK-based startups, scale-ups, and international firms with a growing UK presence. These organisations have recently secured funding, partnerships, or strategic backing—strong indicators of hiring momentum in the months ahead.